Patent · US Active

Core-shell microneedle devices and uses thereof

US11697007B2 · kind B2 · utility

4Cited by
0References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 5, 2017
Grant dateJul 11, 2023
Priority date
Expiry dateNov 10, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y111/01006
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates to microneedle devices and methods for treating a disease (for example, diabetes) using a degradable cross-linked gel for self-regulated delivery of a therapeutic agent (for example, insulin).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.